Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Rep ; 8(1): 15848, 2018 Oct 29.
Article in English | MEDLINE | ID: mdl-30374121

ABSTRACT

A correction has been published and is appended to both the HTML and PDF versions of this paper. The error has not been fixed in the paper.

2.
Sci Rep ; 7: 41407, 2017 02 01.
Article in English | MEDLINE | ID: mdl-28145507

ABSTRACT

Oligodendrocyte precursor cells (OPCs) have the ability to repair demyelinated lesions by maturing into myelin-producing oligodendrocytes. Recent evidence suggests that miR-219 helps regulate the differentiation of OPCs into oligodendrocytes. We performed oligodendrocyte differentiation studies using miR-219-overexpressing mouse embryonic stem cells (miR219-mESCs). The self-renewal and multiple differentiation properties of miR219-mESCs were analyzed by the expression of the stage-specific cell markers Nanog, Oct4, nestin, musashi1, GFAP, Tuj1 and O4. MiR-219 accelerated the differentiation of mESC-derived neural precursor cells (NPCs) into OPCs. We further transplanted OPCs derived from miR219-mESCs (miR219-OPCs) into cuprizone-induced chronically demyelinated mice to observe remyelination, which resulted in well-contained oligodendrocyte grafts that migrated along the corpus callosum and matured to express myelin basic protein (MBP). Ultrastructural studies further confirmed the presence of new myelin sheaths. Improved cognitive function in these mice was confirmed by behavioral tests. Importantly, the transplanted miR219-OPCs induced the proliferation of endogenous NPCs. In conclusion, these data demonstrate that miR-219 rapidly transforms mESCs into oligodendrocyte lineage cells and that the transplantation of miR219-OPCs not only promotes remyelination and improves cognitive function but also enhances the proliferation of host endogenous NPCs following chronic demyelination. These results support the potential of a therapeutic role for miR-219 in demyelinating diseases.


Subject(s)
Demyelinating Diseases/genetics , Demyelinating Diseases/physiopathology , MicroRNAs/metabolism , Oligodendrocyte Precursor Cells/transplantation , Recovery of Function , Remyelination/genetics , Animals , Axons/metabolism , Cell Differentiation , Cell Lineage , Cell Proliferation , Cell Survival , Chronic Disease , Coculture Techniques , Cognition Disorders/physiopathology , Cognition Disorders/therapy , Cuprizone , Disease Models, Animal , Mice , MicroRNAs/genetics , Pluripotent Stem Cells/metabolism
3.
Brain Res Bull ; 130: 60-66, 2017 04.
Article in English | MEDLINE | ID: mdl-28063880

ABSTRACT

Studies have indicated that glutamate receptor subunit 3 peptide B antibodies (GluR3B Ab's) by directing against a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid subtype glutamate receptors (AMPARs) subunit 3 (GluR3B) was involved in the hippocampal neuron damage in the pathogenesis of epilepsy. Glutamate accumulation is critical for oligodendrocyte precursors (OPCs) excitotoxic injury. However, remarkably little is known about whether GluR3B Ab's causes OPCs excitotoxicity, and the underlying mechanisms remain unclear. In this study, we found that the survival rate of OPCs decreased, apoptosis increased and the release of LDH increased with GluR3B Ab's treatment. GluR3B Ab's enhanced the level of intracellular Ca2+ and reactive oxygen species (ROS), caused mitochondrial potential collapse measured by JC-1 and promoted mitochondrial cytochrome C release. AMPARs antagonist NBQX reversed OPCs apoptosis caused by GluR3B Ab's. Taken together, these data suggests that AMPAR was involved in GluR3B Ab's-induced OPCs toxicity by mitochondrial dysfunction. The study revealed a new mechanism for OPCs excitotoxicity in many central nervous system diseases such as epilepsy.


Subject(s)
Mitochondria/immunology , Oligodendrocyte Precursor Cells/immunology , Oligodendrocyte Precursor Cells/physiology , Receptors, AMPA/immunology , Animals , Apoptosis , Autoantibodies , Calcium/metabolism , Cell Survival , Cells, Cultured , Mitochondria/metabolism , Rats, Sprague-Dawley , Reactive Oxygen Species
4.
Cell Mol Neurobiol ; 36(5): 737-43, 2016 Jul.
Article in English | MEDLINE | ID: mdl-26351174

ABSTRACT

In recent years, the role of capsaicin in cancer prevention and treatment has gained people's attention. However, the mechanism of anti-glioma cells by capsaicin has not been elucidated. Here, we discuss the mechanism of capsaicin in U251 cells. Cell viability was detected by MTT and extracellular LDH measurements, while immunofluorescence was performed to measure changes of LC3 in U251 cells. The expressions of LC3II, Puma-α, Beclin1, P62, Procaspase-3, and P53 were observed by immunoblotting. The cell viability decreased and the punctate patterns of LC3 in U251 cells were observed after Capsaicin treatment. Meanwhile, the expressions of Beclin1, P62, and Puma-α increased. After using 3-MA, the expressions of Beclin1 and Procaspase-3 were reduced while those of P53 and Puma-α increased. The expression of LC3II was increased after Pifithrin-α treatment. Therefore, we believed that capsaicin could induce apoptosis in U251 cells, and the inhibition of autophagy could contribute to apoptosis.


Subject(s)
Apoptosis/drug effects , Autophagy/drug effects , Capsaicin/pharmacology , Cell Survival/drug effects , Benzothiazoles/pharmacology , Caspase 3/metabolism , Cell Line, Tumor , Glioma/drug therapy , Humans , Signal Transduction/drug effects , Toluene/analogs & derivatives , Toluene/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...